Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHYF | GALT | TNXP | ||
| Company | Innate Pharma | Galectin Therapeutic | Tonix Pharm Holdings | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 2.1550 | 3.01 | 14.13 | ||
| High | 2.1550 | 3.20 | 14.44 | ||
| Low | 2.1550 | 2.95 | 13.89 | ||
| Latest | 2.1550 | 3.11 | 13.98 | ||
| Change | +0.2500 | +0.13 | +0.04 | ||
| % Change | +13.12% | +4.36% | +0.29% | ||
| Volume | 100 | 401,200 | 338,000 | ||
| 20-Day Average Volume | N/A | 263,680 | 336,470 | ||
| Previous Close | 1.9050 | 2.98 | 13.94 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 2.93 | 14.95 | ||
| 20-Day Raw Stochastic | N/A | 70.42% | 20.05% | ||
| 20-Day Relative Strength | N/A | 46.62 | 39.08 | ||
| Weighted Alpha | N/A | +29.85 | -43.81 | ||
| Today's Opinion | N/A | 72% Sell | 100% Sell | ||
| Previous Opinion | N/A | 72% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 56% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.75% since 09/12/25 | -3.42% since 02/25/26 | -5.80% since 02/25/26 | ||
| Low | 1.9050 on 12/09/25 | 2.86 on 03/03/26 | 13.16 on 03/02/26 | ||
| High | 2.1550 on 12/16/25 | 3.22 on 02/26/26 | 15.03 on 02/26/26 | ||
| 1-Month | |||||
| %Chg | +7.75% since 10/02/25 | +5.07% since 02/04/26 | -13.92% since 02/04/26 | ||
| Low | 1.9050 on 12/09/25 | 2.61 on 02/09/26 | 13.16 on 03/02/26 | ||
| High | 2.1550 on 12/16/25 | 3.32 on 02/25/26 | 16.69 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +7.75% since 09/12/25 | -50.63% since 12/04/25 | -28.42% since 12/04/25 | ||
| Low | 1.9050 on 12/09/25 | 2.61 on 02/09/26 | 13.16 on 03/02/26 | ||
| High | 2.1550 on 12/16/25 | 7.13 on 12/17/25 | 20.56 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | +24.21% since 06/12/25 | -33.40% since 09/04/25 | -46.86% since 09/04/25 | ||
| Low | 1.3100 on 07/07/25 | 2.61 on 02/09/26 | 13.16 on 03/02/26 | ||
| High | 2.1550 on 12/16/25 | 7.13 on 12/17/25 | 31.55 on 09/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 180,654 | 192,130 | 169,692 | ||
| Shares Outstanding, K | 83,830 | 64,473 | 12,173 | ||
| Annual Sales | 21,770,000 | 0 | 10,090,000 | ||
| Annual Net Income | -53,530,000 | -47,050,000 | -130,040,000 | ||
| Last Quarter Sales | N/A | 0 | 3,290,000 | ||
| Last Quarter Net Income | N/A | -8,180,000 | -32,010,000 | ||
| 60-Month Beta | -0.04 | 0.98 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.13 on 11/14/25 | -3.59 on 11/10/25 | ||
| Latest Earnings Date | 03/26/26 | 03/30/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||